EP 2173343 A1 20100414 - USE OF PIMAVANSERIN IN THE TREATMENT OF PARKINSON AND SYMPTOMS THEREOF
Title (en)
USE OF PIMAVANSERIN IN THE TREATMENT OF PARKINSON AND SYMPTOMS THEREOF
Title (de)
VERWENDUNG VON PIMAVANSERIN ZUR BEHANDLUNG VON PARKINSON UND VON SYMPTOMEN DAVON
Title (fr)
UTILISATION DE PIMAVANSÉRINE POUR LE TRAINTEMANT DE LA MALADIE DE PARKINSON ET DES SYMPTÔMES ASSOCIÉ
Publication
Application
Priority
- US 2008064154 W 20080519
- US 93898507 P 20070518
- US 94299007 P 20070608
Abstract (en)
[origin: WO2008144665A1] It is shown that pimavanserin can be administered with or without food without significant effect on absorption or pharmacokinetics. It is also shown that pimavanserin can be used to treat Parkinson's disease psychosis without significantly worsening motor symptoms.
IPC 8 full level
A61K 31/4468 (2006.01); A61K 31/519 (2006.01); A61P 25/28 (2006.01)
CPC (source: EP)
A61K 31/4468 (2013.01); A61K 31/519 (2013.01); A61P 25/16 (2017.12); A61P 25/18 (2017.12); A61P 25/20 (2017.12); A61P 25/28 (2017.12)
Citation (search report)
See references of WO 2008144665A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MT NL NO PL PT RO SE SI SK TR
Designated extension state (EPC)
AL BA MK RS
DOCDB simple family (publication)
WO 2008144665 A1 20081127; AU 2008254669 A1 20081127; CA 2685606 A1 20081127; EP 2173343 A1 20100414; JP 2010527938 A 20100819
DOCDB simple family (application)
US 2008064154 W 20080519; AU 2008254669 A 20080519; CA 2685606 A 20080519; EP 08769520 A 20080519; JP 2010508634 A 20080519